Status:
UNKNOWN
Esophagectomy Enhanced Recovery After Surgery Protocol
Lead Sponsor:
Raquel Ferrandis Comes
Conditions:
Esophagectomy
Eligibility:
All Genders
18-90 years
Brief Summary
Despite the important advances in anaesthesia and the implementation of perioperative care, pulmonary complications in esophagectomy reach figures of between 20 and 35%, and these complications are al...
Detailed Description
Esophageal carcinoma is the sixth leading cause of cancer death worldwide and the main treatment still remains oesophagectomy, a technique associated with a high morbidity and mortality rate. Despite ...
Eligibility Criteria
Inclusion
- Patients undergone esophagectomy due to neoplastic causes
- Ages between 18 and 90
- Programmed surgery
Exclusion
- Caustic esophagitis
- Esophagectomy for stomach cancer
- Congenital oesophageal malformations
- Respiratory failure at the time of surgery
- Re-interventions of esophagectomy
- Unexpected intraoperative surgical problems
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04750096
Start Date
September 1 2020
End Date
December 31 2022
Last Update
February 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
La Fe University and Polytechnic Hospital
Valencia, Spain, 46026